PTC Therapeutics to Host Conference Call to Discuss First Quarter 2021 Financial Results
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
PTC Therapeutics, Inc. (NASDAQ: PTCT) will host a webcast conference call on May 4, 2021, at 4:30 p.m. (ET) to discuss its first quarter 2021 financial results. Investors can access the call by dialing (877) 303-9216 domestically or (973) 935-8152 internationally. The call will be available for replay on the company’s website for 30 days after the event. PTC emphasizes its focus on developing differentiated medicines for rare disorders, reinforcing its commitment to providing best-in-class treatments for patients with unmet medical needs.
Positive
- Company is focused on developing clinically differentiated medicines for rare disorders.
- Strong scientific expertise and global commercial infrastructure aim to maximize value for stakeholders.
Negative
- None.
Details
News Market Reaction – PTCT
The recorded move for PTCT in the trading session of this news was -2.59%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SOUTH PLAINFIELD, N.J., April 20, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its first quarter 2021 financial results and provide an update on the company's business and outlook on Tuesday, May 4, 2021 at 4:30 p.m. (ET) after the closing of the market.
The call can be accessed by dialing (877) 303-9216 (domestic) or (973) 935-8152 (international) five minutes prior to the start of the call and providing the passcode 4292410. A live, listen-only webcast of the conference call can be accessed on the investor relations section of the PTC website at https://ir.ptcbio.com/events-presentations. A webcast replay of the call will be available approximately two hours after completion of the call and will be archived on the company's website for 30 days following the call.
About PTC Therapeutics, Inc.
PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need. The Company's strategy is to leverage its strong scientific expertise and global commercial infrastructure to maximize value for its patients and other stakeholders.
FOR MORE INFORMATION PLEASE CONTACT: | |
Media: | Investors: |
Jane Baj | Kylie O'Keefe |
+1 (908) 912-9167 | +1 (908) 300-0691 |
View original content:http://www.prnewswire.com/news-releases/ptc-therapeutics-to-host-conference-call-to-discuss-first-quarter-2021-financial-results-301269185.html
SOURCE PTC Therapeutics, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.